<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Chemotherapy/Oncology News</title> 
<link>http://www.mdlinx.com/pharmacy/news.cfm/newspage/1/spec_id/24/subspec_id/584</link> 
<description>Chemotherapy/Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2013 MDLinx, Inc.</copyright>



<item> 
<title><![CDATA[An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4640565/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>The Oncologist</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4640565/?xml</guid>
</item> 

<item> 
<title><![CDATA[Novel antibodies targeting immune regulatory checkpoints for cancer therapy]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4641101/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>British Journal of Clinical Pharmacology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4641101/?xml</guid>
</item> 

<item> 
<title><![CDATA[Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4633521/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Cancer Chemotherapy and Pharmacology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4633521/?xml</guid>
</item> 

<item> 
<title><![CDATA[The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4631096/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Current Medical Research and Opinion</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4631096/?xml</guid>
</item> 

<item> 
<title><![CDATA[A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4640824/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>European Journal of Cancer Care</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4640824/?xml</guid>
</item> 

<item> 
<title><![CDATA[A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACAG) in patients with locally advanced carcinoma of the bladder]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4638049/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Urology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4638049/?xml</guid>
</item> 

<item> 
<title><![CDATA[The effect of Echinacea purpurea on the pharmacokinetics of docetaxel]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4641105/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>British Journal of Clinical Pharmacology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4641105/?xml</guid>
</item> 

<item> 
<title><![CDATA[Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4640578/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Tumor Biology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4640578/?xml</guid>
</item> 

<item> 
<title><![CDATA[Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4640592/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>British Journal of Haematology</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4640592/?xml</guid>
</item> 

<item> 
<title><![CDATA[Brassinin induces apoptosis in pc-3 human prostate cancer cells through the suppression of pi3k/akt/mtor/s6k1 signaling cascades]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4634000/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Phytotherapy Research</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4634000/?xml</guid>
</item> 

<item> 
<title><![CDATA[Understanding and targeting cancer stem cells: therapeutic implications and challenges]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4634563/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Acta Pharmacologica Sinica</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4634563/?xml</guid>
</item> 

<item> 
<title><![CDATA[NF-kappaB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants]]></title> 
<link>http://www.mdlinx.com/pharmacy/news-article.cfm/4642029/?xml</link> 
<pubDate>5/24/2013</pubDate> 
<description><![CDATA[<b>Molecular Cancer Therapeutics</b>]]></description> 
<guid>http://www.mdlinx.com/pharmacy/news-article.cfm/4642029/?xml</guid>
</item> 
  


</channel> 
</rss>

